We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Amarex and CardioDynamics Announce Strategic Alliance Agreement

By HospiMedica staff writers
Posted on 02 Jul 2007
A strategic alliance has been formed between Amarex Clinical Research (Germantown, MD, USA) and CardioDynamics (San Diego, CA, USA), which will enable advanced data analysis services through Amarex's secure WebView portal, a parallel-processing system in which detailed cardiovascular tables and graphs are created from real-time trial data that enable sponsors to make advanced cardiac safety assessments in their phase I-IV clinical development programs. More...


Amarex, a full-service clinical research organization (CRO), teamed this with noninvasive hemodynamic data outputs from CardioDynamics' proprietary BioZ Impedance Cardiography (ICG) technology and BioZport application software to provide highly-detailed and customized individual and group data displays of critical cardiac safety and performance variables. Investigators and sponsors can easily view these reports online via the WebView portal, allowing instantaneous decisions relating to dose selection, safety outcomes, and therapeutic efficacy of cardioactive agents.

"We believe that CardioDynamics' ICG technology provides the pharmaceutical industry with an important new level of hemodynamic data that will clearly enhance decision making regarding dosing, patient safety, and patient selection,” said Dr. Kazem Kazempour, president and CEO of Amarex.

Commenting on the strategic alliance, Michael K. Perry, CEO of CardioDynamics, a leading manufacturer and marketer of noninvasive ICG products and medical device electrodes, added "We are very pleased to partner with Amarex and believe that their ‘parallel processing of data' philosophy, highly-regarded reputation in the biometrics and data management field, and extensive global experience in the biopharmaceutical clinical trial arena make them an excellent strategic alliance partner.”


Related Links:
Amarex Clinical Research
CardioDynamics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Newborn Hearing Screener
ALGO 7i
Blood Bank Refrigerator
MBR-705GR-PE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.